港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

荃信生物-B

21.040

+0.6803.34%

成交量：61.26萬

成交額：1,311.31萬

市值：47.78億

市盈率：-12.57

高：22.120

開：20.880

低：20.200

收：20.360

52周最高：36.500

52周最低：5.950

股本：2.27億

香港流通股本：2.27億

量比：0.64

換手率：0.27%

股息：- -

股息率：- -

每股收益(LYR):-1.674

淨資產收益率：-68.26%

總資產收益率：-10.67%

市淨率：19.28

市盈率(LYR):-12.57

市銷率: 13.62

資料載入中...

總覽公司新聞資訊公告

荃信生物-B10月06日遭主力拋售163.6萬元

荃信生物-B10月03日遭主力拋售449.7萬元

荃信生物-B盤中異動早盤股價大跌5.21%

荃信生物-B盤中異動股價大漲5.13%報34.460港元

天風證券：首予荃信生物-B(02509)「買入」評級目標價40.25港元

港股異動 | 醫藥股多數走強特朗普藥品關税影響有限機構稱四季度BD事件值得期待

邁博藥業-B盤中異動股價大跌5.56%

荃信生物-B盤中異動股價大漲5.03%

荃信生物-B09月24日遭主力拋售321.7萬元

荃信生物-B盤中異動下午盤快速下跌5.25%

荃信生物-B09月17日遭主力拋售74.8萬元

荃信生物-B09月16日遭主力拋售113.7萬元

【醫藥生物】創新藥IND審批縮短至30天，看好國產創新產業鏈——醫藥生物行業跨市場週報（202509014）（王明瑞/黃素青）

光大证券研究

荃信生物-B：深耕自免領域單抗雙抗全面佈局

荃信生物-B大幅上漲5.14% 在研藥物QX004N進入III期臨牀試驗

荃信生物-B盤中異動快速下挫5.02%

醫藥生物行業報告：SIRNA療法再現重磅交易關注臨牀數據披露情況

銀屑病藥物專題報告：生物製劑和口服藥物百花齊放銀屑病治療未來可期

港股異動 | 荃信生物-B(02509)再漲超10% 公司成熟管線逐步邁入兑現期賽樂信市場銷售逐步提速

港股異動 | 荃信生物-B(02509)盤中漲超7% 公司加快管線市場潛力兑現雙抗管線均旨在走向國際化市場

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02509/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02509","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02509\",,,,,undefined,":{"symbol":"02509","market":"HK","secType":"STK","nameCN":"荃信生物-B","latestPrice":21.04,"timestamp":1763107691009,"preClose":20.36,"halted":0,"volume":612617,"delay":0,"floatShares":227071600,"shares":227071600,"eps":-1.6738836915328534,"marketStatus":"休市中","change":0.68,"latestTime":"11-14 16:08:11","open":20.88,"high":22.12,"low":20.2,"amount":13113144,"amplitude":0.094303,"askPrice":21.08,"askSize":800,"bidPrice":21.04,"bidSize":4200,"shortable":3,"etf":0,"ttmEps":-0.9452694804060252,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1763343000000},"marketStatusCode":7,"adr":0,"listingDate":1710864000000,"exchange":"SEHK","adjPreClose":20.36,"openAndCloseTimeList":[[1763083800000,1763092800000],[1763096400000,1763107200000]],"volumeRatio":0.641342,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02509\",,,,,undefined,":{"symbol":"02509","floatShares":227071600,"roa":"-10.67%","roe":"-68.26%","lyrEps":-1.673945,"volumeRatio":0.641342,"shares":227071600,"dividePrice":0,"high":22.12,"amplitude":0.094303,"preClose":20.36,"low":20.2,"week52Low":5.95,"pbRate":"19.28","psRate":"13.62","week52High":36.5,"institutionHeld":0,"latestPrice":21.04,"committee":0.68,"eps":-1.6739453693844237,"divideRate":0,"volume":612617,"delay":0,"ttmEps":-0.9453043108969376,"open":20.88,"prevYearClose":7.38,"prevWeekClose":19.25,"prevMonthClose":21.78,"prevQuarterClose":34.88,"fiveDayClose":19.25,"twentyDayClose":28.5,"sixtyDayClose":24.94},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02509\",params:#limit:5,,,undefined,":[{"date":"2025-03-28","symbol":"02509","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743125400000,"name":null,"time":"盤後","dateTimestamp":1743091200000,"actualEps":null},{"date":"2024-08-15","symbol":"02509","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723685400000,"name":null,"time":"","dateTimestamp":1723651200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02509\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02509\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02509\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02509","date":"2025-11-13","current":-22.257383,"percent":0.137931,"low":-38.274716,"twenty":-12.407907,"median":-9.107782,"eighty":-5.151718,"high":-3.10587,"avg":-11.138615,"sd":8.258911,"marketCap":4610921056},"quantilePoints":[{"date":"2024-03-22","current":-9.005941,"twenty":-9.920087,"median":-9.005941,"eighty":-8.797979,"marketCap":4652400020},{"date":"2024-03-28","current":-9.367246,"twenty":-9.484937,"median":-9.005941,"eighty":-8.416995,"marketCap":4821843660},{"date":"2024-04-05","current":-8.872714,"twenty":-9.396669,"median":-8.977885,"eighty":-8.598751,"marketCap":4565907160},{"date":"2024-04-12","current":-9.165919,"twenty":-9.386227,"median":-9.126184,"eighty":-8.830039,"marketCap":4719469060},{"date":"2024-04-19","current":-9.074252,"twenty":-9.304842,"median":-9.125412,"eighty":-8.934406,"marketCap":4668281760},{"date":"2024-04-26","current":-9.882424,"twenty":-9.513374,"median":-9.232059,"eighty":-8.994719,"marketCap":5077780160},{"date":"2024-05-03","current":-10.208268,"twenty":-9.517937,"median":-9.234052,"eighty":-9.046928,"marketCap":5241579520},{"date":"2024-05-10","current":-10.950727,"twenty":-10.058378,"median":-9.328243,"eighty":-9.081967,"marketCap":6018140360},{"date":"2024-05-17","current":-11.513141,"twenty":-10.522167,"median":-9.424295,"eighty":-9.09098,"marketCap":6317937020},{"date":"2024-05-24","current":-11.397533,"twenty":-11.287555,"median":-9.513128,"eighty":-9.098359,"marketCap":6240211960},{"date":"2024-05-31","current":-10.960491,"twenty":-11.380385,"median":-9.702863,"eighty":-9.110289,"marketCap":6007036780},{"date":"2024-06-07","current":-9.736726,"twenty":-11.329803,"median":-9.882424,"eighty":-9.125257,"marketCap":5329718400},{"date":"2024-06-14","current":-9.786262,"twenty":-11.239813,"median":-9.736726,"eighty":-9.134131,"marketCap":5351925560},{"date":"2024-06-21","current":-11.51586,"twenty":-11.394726,"median":-9.834343,"eighty":-9.179147,"marketCap":6284626280},{"date":"2024-06-28","current":-7.449742,"twenty":-11.394726,"median":-9.882424,"eighty":-9.134131,"marketCap":4063910280},{"date":"2024-07-05","current":-8.013266,"twenty":-11.3835,"median":-9.736726,"eighty":-9.096784,"marketCap":4370369088},{"date":"2024-07-12","current":-8.782148,"twenty":-11.375713,"median":-9.612459,"eighty":-8.973485,"marketCap":4796746560},{"date":"2024-07-19","current":-8.033889,"twenty":-11.260937,"median":-9.536435,"eighty":-8.759388,"marketCap":4388134816},{"date":"2024-07-26","current":-8.627957,"twenty":-11.24224,"median":-9.513744,"eighty":-8.627957,"marketCap":4730125080},{"date":"2024-08-02","current":-9.119354,"twenty":-11.155317,"median":-9.51436,"eighty":-8.659337,"marketCap":4996611000},{"date":"2024-08-09","current":-9.602516,"twenty":-11.096166,"median":-9.502501,"eighty":-8.759388,"marketCap":5296407660},{"date":"2024-08-16","current":-9.659156,"twenty":-11.082764,"median":-9.523303,"eighty":-8.782148,"marketCap":5329718400},{"date":"2024-08-23","current":-11.457751,"twenty":-11.24224,"median":-9.560506,"eighty":-8.785621,"marketCap":5274200500},{"date":"2024-08-30","current":-11.261539,"twenty":-11.260937,"median":-9.602516,"eighty":-8.853804,"marketCap":5218682600},{"date":"2024-09-06","current":-12.381731,"twenty":-11.301814,"median":-9.616314,"eighty":-8.872714,"marketCap":5740550860},{"date":"2024-09-13","current":-12.966504,"twenty":-11.41285,"median":-9.666597,"eighty":-8.919616,"marketCap":5995933200},{"date":"2024-09-20","current":-13.175636,"twenty":-11.495182,"median":-9.727036,"eighty":-8.943786,"marketCap":6129176160},{"date":"2024-09-27","current":-11.412309,"twenty":-11.503472,"median":-9.834343,"eighty":-8.968754,"marketCap":5340821980},{"date":"2024-10-04","current":-10.630177,"twenty":-11.500266,"median":-9.955419,"eighty":-8.992959,"marketCap":4952196680},{"date":"2024-10-10","current":-9.640046,"twenty":-11.496891,"median":-9.984689,"eighty":-9.012278,"marketCap":4463639160},{"date":"2024-10-18","current":-7.823087,"twenty":-11.483911,"median":-9.882424,"eighty":-8.891475,"marketCap":3602001352},{"date":"2024-10-25","current":-6.637022,"twenty":-11.464072,"median":-9.731881,"eighty":-8.768492,"marketCap":3055705216},{"date":"2024-11-01","current":-6.266219,"twenty":-11.439791,"median":-9.666597,"eighty":-8.552796,"marketCap":2886930800},{"date":"2024-11-08","current":-6.11978,"twenty":-11.412634,"median":-9.628889,"eighty":-8.354641,"marketCap":2798102160},{"date":"2024-11-15","current":-4.903744,"twenty":-11.406399,"median":-9.610023,"eighty":-8.146037,"marketCap":2225157432},{"date":"2024-11-22","current":-4.446271,"twenty":-11.39192,"median":-9.574881,"eighty":-7.917147,"marketCap":2016410128},{"date":"2024-11-29","current":-5.262129,"twenty":-11.380385,"median":-9.536435,"eighty":-7.700796,"marketCap":2385048984},{"date":"2024-12-06","current":-5.795133,"twenty":-11.346153,"median":-9.513744,"eighty":-7.24659,"marketCap":2620444880},{"date":"2024-12-13","current":-4.23234,"twenty":-11.292835,"median":-9.462151,"eighty":-6.614509,"marketCap":1912036476},{"date":"2024-12-20","current":-3.65763,"twenty":-11.272236,"median":-9.353096,"eighty":-6.423955,"marketCap":1643329840},{"date":"2024-12-27","current":-3.704989,"twenty":-11.261539,"median":-9.289241,"eighty":-6.377951,"marketCap":1663316284},{"date":"2025-01-03","current":-3.459219,"twenty":-11.261057,"median":-9.234052,"eighty":-6.353973,"marketCap":1554501200},{"date":"2025-01-10","current":-3.422771,"twenty":-11.250301,"median":-9.146052,"eighty":-6.232964,"marketCap":1532294040},{"date":"2025-01-17","current":-3.325837,"twenty":-11.24332,"median":-9.119354,"eighty":-5.607796,"marketCap":1490100436},{"date":"2025-01-24","current":-3.940539,"twenty":-11.188065,"median":-9.092192,"eighty":-5.378133,"marketCap":1776572800},{"date":"2025-01-28","current":-4.706176,"twenty":-11.17068,"median":-9.087355,"eighty":-5.266211,"marketCap":2131887360},{"date":"2025-02-07","current":-3.301677,"twenty":-11.154739,"median":-9.066381,"eighty":-4.958001,"marketCap":1487879720},{"date":"2025-02-14","current":-3.418254,"twenty":-11.143754,"median":-8.989713,"eighty":-4.539173,"marketCap":1536735472},{"date":"2025-02-21","current":-3.43891,"twenty":-11.106485,"median":-8.919616,"eighty":-4.354459,"marketCap":1554501200},{"date":"2025-02-28","current":-3.351703,"twenty":-11.093486,"median":-8.819713,"eighty":-4.122814,"marketCap":1510086880},{"date":"2025-03-07","current":-3.387392,"twenty":-11.071174,"median":-8.759388,"eighty":-3.975573,"marketCap":1532294040},{"date":"2025-03-14","current":-5.398225,"twenty":-11.023325,"median":-8.622598,"eighty":-3.975573,"marketCap":2442787600},{"date":"2025-03-21","current":-4.408646,"twenty":-11.005989,"median":-8.475358,"eighty":-3.996365,"marketCap":1994202968},{"date":"2025-03-28","current":-4.427424,"twenty":-10.958538,"median":-8.354936,"eighty":-4.069456,"marketCap":1998644400},{"date":"2025-04-03","current":-5.532239,"twenty":-10.950727,"median":-8.251895,"eighty":-4.071454,"marketCap":1987540820},{"date":"2025-04-11","current":-5.176788,"twenty":-10.949179,"median":-8.134698,"eighty":-4.113712,"marketCap":1843194280},{"date":"2025-04-17","current":-5.605956,"twenty":-10.931954,"median":-8.013266,"eighty":-4.15012,"marketCap":1998644400},{"date":"2025-04-25","current":-6.813611,"twenty":-10.860673,"median":-7.855635,"eighty":-4.203093,"marketCap":2433904736},{"date":"2025-05-02","current":-6.97286,"twenty":-10.741685,"median":-7.823087,"eighty":-4.240312,"marketCap":2496084784},{"date":"2025-05-09","current":-6.850326,"twenty":-10.62989,"median":-7.688151,"eighty":-4.256936,"marketCap":2469436192},{"date":"2025-05-16","current":-6.660384,"twenty":-10.625613,"median":-7.362552,"eighty":-4.28571,"marketCap":2420580440},{"date":"2025-05-23","current":-6.920763,"twenty":-10.596701,"median":-7.188701,"eighty":-4.327055,"marketCap":2522733376},{"date":"2025-05-30","current":-6.975387,"twenty":-10.531077,"median":-7.035719,"eighty":-4.335168,"marketCap":2553823400},{"date":"2025-06-06","current":-8.954176,"twenty":-10.530643,"median":-7.056435,"eighty":-4.354459,"marketCap":3286659680},{"date":"2025-06-13","current":-10.1118,"twenty":-10.525842,"median":-7.245424,"eighty":-4.362058,"marketCap":3713037152},{"date":"2025-06-20","current":-9.295434,"twenty":-10.49786,"median":-7.449742,"eighty":-4.377592,"marketCap":3406578344},{"date":"2025-06-27","current":-9.088195,"twenty":-10.44408,"median":-7.654473,"eighty":-4.399074,"marketCap":3339956864},{"date":"2025-07-04","current":-9.256954,"twenty":-10.441448,"median":-7.771425,"eighty":-4.408646,"marketCap":3402136912},{"date":"2025-07-11","current":-9.278386,"twenty":-10.438605,"median":-7.855635,"eighty":-4.408983,"marketCap":3406578344},{"date":"2025-07-18","current":-10.375245,"twenty":-10.375245,"median":-8.023578,"eighty":-4.415927,"marketCap":3806307224},{"date":"2025-07-25","current":-11.242346,"twenty":-10.444738,"median":-8.163045,"eighty":-4.427424,"marketCap":4139414624},{"date":"2025-08-01","current":-12.956889,"twenty":-10.531115,"median":-8.317696,"eighty":-4.446271,"marketCap":4741228660},{"date":"2025-08-08","current":-12.531071,"twenty":-10.816023,"median":-8.356409,"eighty":-4.497422,"marketCap":4596882120},{"date":"2025-08-15","current":-13.616918,"twenty":-10.950727,"median":-8.486422,"eighty":-4.706176,"marketCap":4987728136},{"date":"2025-08-22","current":-28.922954,"twenty":-11.024815,"median":-8.611071,"eighty":-4.860396,"marketCap":6035906088},{"date":"2025-08-29","current":-26.076607,"twenty":-11.152426,"median":-8.643647,"eighty":-4.89511,"marketCap":5467884128},{"date":"2025-09-05","current":-27.424941,"twenty":-11.24224,"median":-8.759388,"eighty":-4.895913,"marketCap":5744911480},{"date":"2025-09-12","current":-33.976118,"twenty":-11.261539,"median":-8.783884,"eighty":-4.903744,"marketCap":7130048240},{"date":"2025-09-19","current":-32.137812,"twenty":-11.3835,"median":-8.872714,"eighty":-4.920955,"marketCap":6739485088},{"date":"2025-09-26","current":-31.917438,"twenty":-11.446602,"median":-8.942813,"eighty":-4.93749,"marketCap":6675905040},{"date":"2025-10-03","current":-36.693474,"twenty":-11.494681,"median":-8.957754,"eighty":-4.939756,"marketCap":7693185808},{"date":"2025-10-10","current":-31.866218,"twenty":-11.50418,"median":-8.989713,"eighty":-4.971797,"marketCap":6671363608},{"date":"2025-10-17","current":-31.02267,"twenty":-11.536491,"median":-9.052042,"eighty":-5.060821,"marketCap":6489706328},{"date":"2025-10-24","current":-25.824743,"twenty":-11.67702,"median":-9.080681,"eighty":-5.119056,"marketCap":5404304080},{"date":"2025-10-31","current":-23.597698,"twenty":-11.854109,"median":-9.087898,"eighty":-5.129572,"marketCap":4945619448},{"date":"2025-11-07","current":-20.869587,"twenty":-12.197299,"median":-9.096784,"eighty":-5.138538,"marketCap":4371128300},{"date":"2025-11-13","current":-21.952253,"twenty":-12.407907,"median":-9.107782,"eighty":-5.151718,"marketCap":4610921056}],"updateTime":1763147523756},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02509\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2573602989","title":"荃信生物-B10月06日遭主力拋售163.6萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2573602989","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573602989?lang=zh_tw&edition=fundamental","pubTime":"2025-10-06 16:15","pubTimestamp":1759738536,"startTime":"0","endTime":"0","summary":"10月06日, 荃信生物-B股价跌2.01%，报收33.20元，成交金额555.6万元，换手率0.07%，振幅10.92%，量比0.17。荃信生物-B今日主力资金净流出163.6万元，连续3日净流出，上一交易日主力净流出449.7万元。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为71.43%，平均跌幅为2.52%。该股近5个交易日上涨12.86%，主力资金累计净流出1408.5万元；近20日主力资金累计净流出1781.0万元，其中净流出天数为14日。该股主力净额占比0.02%，港股市场排名2511/2674。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251006161800a454ea2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251006161800a454ea2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2572631590","title":"荃信生物-B10月03日遭主力拋售449.7萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572631590","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572631590?lang=zh_tw&edition=fundamental","pubTime":"2025-10-03 16:15","pubTimestamp":1759479330,"startTime":"0","endTime":"0","summary":"10月03日, 荃信生物-B股价跌4.13%，报收33.88元，成交金额1652.3万元，换手率0.21%，振幅8.38%，量比0.46。荃信生物-B今日主力资金净流出449.7万元，上一交易日主力净流出513.2万元。该股近5个交易日上涨15.87%，主力资金累计净流出1396.9万元；近20日主力资金累计净流出1419.7万元，其中净流出天数为13日。该股主力净额占比0.06%，港股市场排名2596/2673。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003161724a6abefdd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003161724a6abefdd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2572631515","title":"荃信生物-B盤中異動 早盤股價大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572631515","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572631515?lang=zh_tw&edition=fundamental","pubTime":"2025-10-03 10:23","pubTimestamp":1759458212,"startTime":"0","endTime":"0","summary":"2025年10月03日早盘10时23分，荃信生物-B股票出现波动，股价快速跳水5.21%。截至发稿，该股报33.500港元/股，成交量14.04万股，换手率0.06%，振幅8.38%。荃信生物-B股票所在的生物技术行业中，整体跌幅为2.78%。其相关个股中，三叶草生物-B、银诺医药-B、腾盛博药-B涨幅较大，振幅较大的相关个股有MIRXES-B、三叶草生物-B、荃信生物-B，振幅分别为9.53%、9.45%、8.38%。荃信生物-B公司简介：江苏荃信生物医药股份有限公司是一家主要从事生物制药的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003102332971de14d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003102332971de14d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2571130693","title":"荃信生物-B盤中異動 股價大漲5.13%報34.460港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2571130693","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571130693?lang=zh_tw&edition=fundamental","pubTime":"2025-09-30 13:44","pubTimestamp":1759211061,"startTime":"0","endTime":"0","summary":"2025年09月30日下午盘13时44分，荃信生物-B股票出现异动，股价急速拉升5.13%。截至发稿，该股报34.460港元/股，成交量75.8万股，换手率0.33%，振幅7.87%。资金方面，该股资金流入1289.98万港元，流出1071.61万港元。荃信生物-B股票所在的生物技术行业中，整体涨幅为3.58%。其相关个股中，三叶草生物-B、华领医药-B、MIRXES-B涨幅较大，振幅较大的相关个股有云康集团、MIRXES-B、思路迪医药股份，振幅分别为23.48%、15.32%、12.21%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509301344219719b4b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509301344219719b4b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2571399927","title":"天風證券：首予荃信生物-B(02509)「買入」評級 目標價40.25港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2571399927","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571399927?lang=zh_tw&edition=fundamental","pubTime":"2025-09-30 10:54","pubTimestamp":1759200864,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，天风证券发布研报称，首次覆盖荃信生物-B，给予“买入”评级，预计公司2025-2027年营业收入分别为3.22/4.41/5.93亿元人民币。给予公司2025年26倍PS，对应目标价36.85元人民币，对应40.25元港币。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1351083.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["601162","02509"],"gpt_icon":0},{"id":"2571880159","title":"港股異動 | 醫藥股多數走強 特朗普藥品關税影響有限 機構稱四季度BD事件值得期待","url":"https://stock-news.laohu8.com/highlight/detail?id=2571880159","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571880159?lang=zh_tw&edition=fundamental","pubTime":"2025-09-29 14:41","pubTimestamp":1759128116,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，医药股多数走强。消息面上，当地时间9月25日，特朗普宣布将对专利及品牌药品加征100%关税，唯一豁免条件是药企已在美国“IS BUILDING”（在建）制药工厂。交银国际认为，这对中国创新药产业链影响有限，无需过度担忧。该行分析历年来全球BD事件，重磅BD交易落地集中在年底。随着10月起ESMO会议等一系列权威学术会议召开，BD事件值得期待。继续看好中国创新药全球竞争力提升，自身经营改善以及BD合作密集落地的产业趋势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3452d085f48a0e569f128ec4585d109f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1350517.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2328871848.SGD","BK1574","LU1969619763.USD","BK1617","BK1161","01167","02228","09995","01541","159938","BK1583","BK4614","HSCEI","YANG","09939","02509","BK1141","BK1515"],"gpt_icon":1},{"id":"2571804293","title":"邁博藥業-B盤中異動 股價大跌5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2571804293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571804293?lang=zh_tw&edition=fundamental","pubTime":"2025-09-29 11:29","pubTimestamp":1759116579,"startTime":"0","endTime":"0","summary":"2025年09月29日早盘11时29分，迈博药业-B股票出现异动，股价快速跳水5.56%。截至发稿，该股报0.680港元/股，成交量124.8万股，换手率0.03%，振幅5.56%。迈博药业-B股票所在的生物技术行业中，整体涨幅为0.13%。迈博药业-B公司简介：迈博药业有限公司是一家主要从事癌症及自身免疫性疾病的单抗药物的研究、开发及生产的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929112939a44b4dad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929112939a44b4dad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02181","BK1574","02509","02105","BK1161"],"gpt_icon":0},{"id":"2571874683","title":"荃信生物-B盤中異動 股價大漲5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2571874683","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571874683?lang=zh_tw&edition=fundamental","pubTime":"2025-09-29 10:18","pubTimestamp":1759112281,"startTime":"0","endTime":"0","summary":"2025年09月29日早盘10时18分，荃信生物-B股票出现波动，股价大幅拉升5.03%。截至发稿，该股报30.880港元/股，成交量26.34万股，换手率0.12%，振幅7.14%。荃信生物-B股票所在的生物技术行业中，整体跌幅为0.39%。其相关个股中，宜明昂科-B、晶泰控股、映恩生物-B涨幅较大，振幅较大的相关个股有来凯医药-B、宜明昂科-B、北海康成-B，振幅分别为27.08%、10.59%、8.09%。荃信生物-B公司简介：江苏荃信生物医药股份有限公司是一家主要从事生物制药的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092910180197afe832&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092910180197afe832&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2570069933","title":"荃信生物-B09月24日遭主力拋售321.7萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2570069933","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570069933?lang=zh_tw&edition=fundamental","pubTime":"2025-09-24 16:15","pubTimestamp":1758701754,"startTime":"0","endTime":"0","summary":"09月24日, 荃信生物-B股价跌0.41%，报收29.48元，成交金额1849.1万元，换手率0.28%，振幅5.61%，量比0.74。荃信生物-B今日主力资金净流出321.7万元，连续3日净流出，上一交易日主力净流出36.1万元。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为66.67%，平均跌幅为3.05%。该股近5个交易日下跌5.93%，主力资金累计净流出285.8万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入27.6万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250924170606a69aebfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250924170606a69aebfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2568225745","title":"荃信生物-B盤中異動 下午盤快速下跌5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568225745","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568225745?lang=zh_tw&edition=fundamental","pubTime":"2025-09-19 14:00","pubTimestamp":1758261615,"startTime":"0","endTime":"0","summary":"2025年09月19日下午盘14时00分，荃信生物-B股票出现异动，股价急速下挫5.25%。截至发稿，该股报29.940港元/股，成交量39.56万股，换手率0.17%，振幅5.38%。荃信生物-B股票所在的生物技术行业中，整体跌幅为4.48%。荃信生物-B公司简介：江苏荃信生物医药股份有限公司是一家主要从事生物制药的中国公司。该公司主要从事自体免疫及过敏性疾病生物疗法的生物科技研发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091914001695380469&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091914001695380469&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2568446703","title":"荃信生物-B09月17日遭主力拋售74.8萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568446703","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568446703?lang=zh_tw&edition=fundamental","pubTime":"2025-09-17 16:15","pubTimestamp":1758096914,"startTime":"0","endTime":"0","summary":"09月17日, 荃信生物-B股价跌3.66%，报收31.04元，成交金额1871.7万元，换手率0.26%，振幅6.15%，量比0.53。荃信生物-B今日主力资金净流出74.8万元，连续3日净流出，上一交易日主力净流出113.7万元。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为80.00%，平均跌幅为3.05%。该股近5个交易日上涨11.25%，主力资金累计净流入666.8万元；近20日主力资金累计净流出95.8万元，其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091716244497982278&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091716244497982278&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2568487514","title":"荃信生物-B09月16日遭主力拋售113.7萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568487514","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568487514?lang=zh_tw&edition=fundamental","pubTime":"2025-09-16 16:15","pubTimestamp":1758010510,"startTime":"0","endTime":"0","summary":"09月16日, 荃信生物-B股价跌0.25%，报收32.22元，成交金额1762.7万元，换手率0.24%，振幅4.40%，量比0.47。荃信生物-B今日主力资金净流出113.7万元，上一交易日主力净流出46.3万元。该股近5个交易日上涨17.37%，主力资金累计净流入193.0万元；近20日主力资金累计净流出339.0万元，其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250916161552979597bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250916161552979597bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2567173200","title":"【醫藥生物】創新藥IND審批縮短至30天，看好國產創新產業鏈——醫藥生物行業跨市場週報（202509014）（王明瑞/黃素青）","url":"https://stock-news.laohu8.com/highlight/detail?id=2567173200","media":"光大证券研究","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567173200?lang=zh_tw&edition=fundamental","pubTime":"2025-09-16 07:01","pubTimestamp":1757977314,"startTime":"0","endTime":"0","summary":"报告摘要行情回顾：上周，A股医药生物指数下跌0.36%，跑输沪深300指数1.75pp，跑输创业板综指2.37pp，在31个子行业中排名第28。本周观点：创新药IND审批缩短至30天，看好国产创新产业链9月12日，国家药监局发布《关于优化创新药临床试验审评审批有关事项的公告》，标志着我国创新药IND审批正式迈入“30天”高效时代。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250916071506952ffe35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250916071506952ffe35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","BK1161","02509","01276","09969","02162","BK1574"],"gpt_icon":0},{"id":"2567186026","title":"荃信生物-B：深耕自免領域 單抗雙抗全面佈局","url":"https://stock-news.laohu8.com/highlight/detail?id=2567186026","media":"华创证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567186026?lang=zh_tw&edition=fundamental","pubTime":"2025-09-13 07:32","pubTimestamp":1757719920,"startTime":"0","endTime":"0","summary":"公司基于丰富的单抗分子积累，高效推进长效自免双抗研发，首个双抗预计2025 年第四季度获批IND，2025年内还计划申报2 个双抗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250913084633a71e840d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250913084633a71e840d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2567990021","title":"荃信生物-B大幅上漲5.14% 在研藥物QX004N進入III期臨牀試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2567990021","media":"港美通","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567990021?lang=zh_tw&edition=fundamental","pubTime":"2025-09-12 15:44","pubTimestamp":1757663091,"startTime":"0","endTime":"0","summary":"9月12日15:33，荃信生物-B大幅上涨5.14%，该股报30.260港元，最高报30.260港元，最低报27.600港元，成交量111.06万股，成交额3196.51万港元。消息面上，公司近日发布公告称，其在研药物QX004N是一款针对白介素23p19亚基的抑制剂，拟用于治疗银屑病及克罗恩病。近期，该药物已进入III期临床试验，成为公司管线中第四个进入III期阶段的产品。近日，公司已收到翰森制药根据协议支付的银屑病III期里程碑及其他款项，合计5800万元。期内亏损为3093.3万元，同比大幅缩减83.11%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250912155040a4c2678c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250912155040a4c2678c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02509","BK1583","BK1161","BK1589","03692"],"gpt_icon":0},{"id":"2566952727","title":"荃信生物-B盤中異動 快速下挫5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566952727","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566952727?lang=zh_tw&edition=fundamental","pubTime":"2025-09-11 09:30","pubTimestamp":1757554209,"startTime":"0","endTime":"0","summary":"2025年09月11日早盘09时30分，荃信生物-B股票出现波动，股价急速跳水5.02%。荃信生物-B股票所在的生物技术行业中，整体跌幅为9.84%。该信息摘要如下：荃信生物-B再涨超10%，截至发稿，涨9.64%，报27.74港元，成交额1869.43万港元。据悉，赛乐信2024年10月获国家药监局批准上市。据了解，荃信生物-B的第二大股东为华东医药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091109301095235f28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091109301095235f28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2566669619","title":"醫藥生物行業報告：SIRNA療法再現重磅交易 關注臨牀數據披露情況","url":"https://stock-news.laohu8.com/highlight/detail?id=2566669619","media":"中邮证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566669619?lang=zh_tw&edition=fundamental","pubTime":"2025-09-09 00:00","pubTimestamp":1757347200,"startTime":"0","endTime":"0","summary":"本周主题本周诺华相继引进Arrowhead 和舶望制药的siRNA 药物，行业关注度大幅提升。恒生医疗保健指数上涨7.07%，板块整体跑赢恒生指数5.72pct。在恒生12个一级子行业中，医疗保健行业周涨跌幅排名为第1 位。以及疫情诊疗相关药品高基数影响减弱，库存恢复常态水平，业绩增速有望恢复。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250909143750a718a9bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250909143750a718a9bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348783233.USD","02359","06978","LU0348784397.USD","LU0417516902.SGD","02509","LU0348825331.USD","LU0348767384.USD","LU0417516738.SGD","IE00B543WZ88.USD","LU0348827113.USD","BK1574","LU1794554557.SGD","LU1720050803.USD","BK1161","LU2778985437.USD","LU2488822045.USD","LU0561508036.HKD","09926","LU2476274720.SGD","IE00BPRC5H50.USD","01276","LU0417516571.SGD","IE00B5MMRT66.SGD","LU0540923850.HKD","LU0348766576.USD","LU0348735423.USD","LU2476274308.USD","LU0634319403.HKD"],"gpt_icon":1},{"id":"2566660598","title":"銀屑病藥物專題報告：生物製劑和口服藥物百花齊放 銀屑病治療未來可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2566660598","media":"华鑫证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566660598?lang=zh_tw&edition=fundamental","pubTime":"2025-09-09 00:00","pubTimestamp":1757347200,"startTime":"0","endTime":"0","summary":"银屑病现阶段还无法彻底治愈，需要长期治疗以控制病情，治疗需求庞大。根据数据统计，全球银屑病治疗市场2022年规模为265亿美元。针对银屑病，目前已经开发多种类型、多个靶点的口服药物。随着生物制剂、口服靶向药等创新药的涌现，银屑病治疗进入“精准时代”，未来银屑病患者治疗可期。口服类药物，高效安全便捷的小分子TYK2和肽类药物因其显著优势，有望成为银屑病患者的新选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250909165628a4bdd276&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250909165628a4bdd276&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2565078579","title":"港股異動 | 荃信生物-B(02509)再漲超10% 公司成熟管線逐步邁入兑現期  賽樂信市場銷售逐步提速","url":"https://stock-news.laohu8.com/highlight/detail?id=2565078579","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565078579?lang=zh_tw&edition=fundamental","pubTime":"2025-09-08 10:23","pubTimestamp":1757298231,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，荃信生物-B再涨超10%，截至发稿，涨9.64%，报27.74港元，成交额1869.43万港元。公司的成熟管线逐步迈入兑现期提升造血能力，同时创新性管线迎来出海机遇。据悉，赛乐信2024年10月获国家药监局批准上市。截至2025年6月，荃信生物-B已向中美华东发货超过60000支。华东医药的销售网络遍布全国30多个省，销售人员超1万人。如荃信生物-B已经商业化的赛乐信在华东医药的销售下，上半年已开具处方医院数量超过1200家，市场销售逐步提速。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1342457.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1235295612.USD","BK4531","LX","LU1046422090.SGD","BK1161","BK4579","02509","BK4166","LU0049112450.USD"],"gpt_icon":0},{"id":"2565358845","title":"港股異動 | 荃信生物-B(02509)盤中漲超7% 公司加快管線市場潛力兑現 雙抗管線均旨在走向國際化市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2565358845","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565358845?lang=zh_tw&edition=fundamental","pubTime":"2025-09-05 11:25","pubTimestamp":1757042742,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，荃信生物-B盘中涨超7%，截至发稿，涨6.13%，报24.94港元，成交额1220.69万港元。消息面上，荃信生物中期业绩显示，上半年收入人民币2.06亿元，同比增加359.69%；期内亏损3093.3万元，同比减少83.11%。目前除了QX002外其余产品之后均与国内Pharma达成合作，交予其负责商业化销售，加快管线市场潜力兑现。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1341861.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02509"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":3,"totalSize":104,"code":"91000000","status":"200"}]}}